Clinical Trial Update: Recurrence Risk Evaluation by 21-gene Detection

View source ↗

Summary

A completed clinical trial from Xijing Hospital evaluating recurrence risk in breast cancer using the 21-gene recurrence score assay, focusing on relationship a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Xijing Hospital | Conditions: Relationship and Consistency Analysis | Status: COMPLETED